硫酸軟骨素市場:按產地、地區 - 市場規模、份額、展望、機會分析,2023-2030 年
市場調查報告書
商品編碼
1330169

硫酸軟骨素市場:按產地、地區 - 市場規模、份額、展望、機會分析,2023-2030 年

Chondroitin Sulfate Market, By Source (Bovine, Swine, Poultry ), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

硫酸軟骨素是一種在促進軟骨、骨骼和結締組織健康方面發揮重要作用的分子。 硫酸軟骨素用於治療骨關節炎等各種骨骼疾病。 骨關節炎是一種痛苦的疾病,會導致關節發炎和僵硬。 這種疾病的發生涉及多種因素,包括老化、遺傳、不良飲食習慣和肥胖。 硫酸軟骨素被廣泛用作治療骨關節炎的自然療法。 此外,它還充當抗炎劑。

市場動態:

由於對營養補充品的需求不斷增加,全球硫酸軟骨素市場正在成長。 這主要是由於人口老化的增加,老年人更容易患骨關節炎等骨骼相關疾病。 推動市場的另一個因素是越來越多地使用硫酸軟骨素作為眼藥水的成分,以幫助治療乾眼症。 此外,它是動物飼料中的常見添加劑,可促進生長和減輕壓力。

另一方面,原物料價格的波動預計將限制市場成長。

本研究的主要特點

  • 本報告詳細分析了全球硫酸軟骨素市場,並提供了以 2022 年為基準年的預測期(2023-2030 年)的市場規模和復合年增長率 (CAGR%)。
  • 它也揭示了各個細分市場的潛在收入機會,並解釋了該市場有吸引力的投資主張矩陣。
  • 它還提供了有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採取的競爭策略等的重要見解。
  • 本報告根據公司亮點、產品組合、主要成就、財務表現和策略等參數,介紹了全球硫酸軟骨素市場的主要參與者。
  • 本研究涵蓋的主要公司包括 TSI 集團有限公司、青島萬圖民生物製品有限公司、河北三鑫實業集團、Bioiberica S.A.U.、Sigma-Aldrich, Inc.、Sino Siam Biotechnique Company Limited、Bio-gen Extracts Private Limited、SEIKAGAKU CORPORATION、BRF 和ZPD。
  • 該報告的見解將使行銷人員和公司高層能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 《全球硫酸軟骨素市場報告》面向該產業的各個利害關係人,例如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球硫酸軟骨素市場的各種策略矩陣,將有助於利害關係人做出決策。

目錄

第1章研究目的與前提

  • 研究目的
  • 先決條件
  • 縮寫

第2章市場概述

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • 連貫的機會地圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 骨關節炎增加
    • 原物料價格不穩定
    • 製藥業的擴張
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第 4 章硫酸軟骨素的世界市場 - 冠狀病毒 (COVID-19) 流行的影響

  • COVID-19 的流行病學
  • 供給面與需求面分析
  • 經濟影響

第5章硫酸軟骨素的全球市場:依來源劃分,2023-2030

  • 家禽

第 6 章硫酸軟骨素全球市場(按地區),2023-2030 年

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第7章競爭態勢

  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • HeBei SanXin Industrial Group
  • Bioiberica S.A.U.
  • Sigma-Aldrich, Inc.
  • Sino Siam Biotechnique Company Limited
  • Bio-gen Extracts Private Limited
  • SEIKAGAKU CORPORATION
  • BRF
  • ZPD

第 8 章部分

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6000

Chondroitin sulfate is an important molecule that plays a key role in promoting healthy cartilage, bones, and connective tissues. It is used in the treatment of various skeletal conditions, such as osteoarthritis. Osteoarthritis is a painful condition, which leads to inflammation and stiffness of joints. Several factors are responsible for the emergence of the disease, including age, genetics, poor diet, and obesity. Chondroitin sulfate is widely used as a natural remedy to treat osteoarthritis. Moreover, it also acts as an anti-inflammatory agent.

Market Dynamics:

The global chondroitin sulfate market is growing on the account of increasing demand for dietary supplements. This is mainly due to the increase in the aging population, which makes them more susceptible to bone-related diseases such as osteoarthritis. Another factor driving the market is the growing use of chondroitin sulfate as an ingredient in eye drops, which helps in treating dry eyes. In addition, it is a common additive in animal feed to enhance growth and reduce stress.

On the other hand, fluctuating price of raw materials is expected to restrict the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global chondroitin sulfate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global chondroitin sulfate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include TSI Group Ltd., Qingdao Wan Toulmin Biological Products Co., Ltd, HeBei SanXin Industrial Group, Bioiberica S.A.U., Sigma-Aldrich, Inc., Sino Siam Biotechnique Company Limited, Bio-gen Extracts Private Limited, SEIKAGAKU CORPORATION, BRF, and ZPD
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global chondroitin sulfate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chondroitin sulfate market

Detailed Segmentation:

  • Global Chondroitin Sulfate Market, By Source
    • Bovine
      • Nutraceuticals
      • Pharmaceuticals
      • Animal Feed
      • Personal Care & Cosmetics
      • Others
    • Swine
      • Nutraceuticals
      • Pharmaceuticals
      • Animal Feed
      • Personal Care & Cosmetics
      • Others
    • Poultry
      • Shark
      • Synthetic
  • Global Chondroitin Sulfate Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Central and South America
    • Middle East
    • Africa
  • Company Profiles
    • TSI Group Ltd.
    • Qingdao Wan Toulmin Biological Products Co., Ltd
    • HeBei SanXin Industrial Group
    • Bioiberica S.A.U.
    • Sigma-Aldrich, Inc.
    • Sino Siam Biotechnique Company Limited
    • Bio-gen Extracts Private Limited
    • SEIKAGAKU CORPORATION
    • BRF
    • ZPD

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Source
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing prevalence of osteoarthritis
    • Volatile price of raw materials
    • Expanding pharmaceutical industry
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Chondroitin Sulfate Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Chondroitin Sulfate Market , By Source, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Bovine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Nutraceuticals
  • Pharmaceuticals
  • Animal Feed
  • Personal Care & Cosmetics
  • Others
  • Swine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Nutraceuticals
  • Pharmaceuticals
  • Animal Feed
  • Personal Care & Cosmetics
  • Others
  • Poultry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Shark
  • Synthetic

6. Global Chondroitin Sulfate Market , By Region, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2023 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Central and South America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)

7. Competitive Landscape

  • TSI Group Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Qingdao Wan Toulmin Biological Products Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • HeBei SanXin Industrial Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bioiberica S.A.U.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sigma-Aldrich, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sino Siam Biotechnique Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-gen Extracts Private Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SEIKAGAKU CORPORATION
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BRF
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ZPD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

8. Section

  • Research Methodology
  • About us